检索规则说明:AND代表“并且”;OR代表“或者”;NOT代表“不包含”;(注意必须大写,运算符两边需空一格)
检 索 范 例 :范例一: (K=图书馆学 OR K=情报学) AND A=范并思 范例二:J=计算机应用与软件 AND (U=C++ OR U=Basic) NOT M=Visual
机构地区:[1]四川泸州医学院附属医院心内科,四川泸州646000
出 处:《中国现代医学杂志》2006年第1期120-122,共3页China Journal of Modern Medicine
摘 要:目的观察替米沙坦对慢性充血性心力衰竭血栓前状态的影响。方法将45例慢性充血性心力衰竭患者随机分为替米沙坦组和对照组,替米沙坦组口服替米沙坦80mg,每天1次,共2周。对照组除不服用替米沙坦外,其他用药与替米沙坦相同。治疗前和治疗2周后测量2组血浆tPA、PAI活性,以及D-二聚体(D-D)和VWF水平。结果替米沙坦组和对照组在治疗前血浆tPA、PAI活性、D-二聚体(D-D)和VWF水平差异无显著性(P>0.05)。替米沙坦组治疗后血浆tPA活性显著性增高(P<0.05),血浆PAI活性、D-D和VWF水平均有显著性下降(P<0.05),而对照组却无显著性改变(P>0.05)。组间比较发现,替米沙坦组治疗后血浆PAI活性、D-D和VWF水平比对照组更低(P<0.05),而血浆tPA活性却无显著性增高(P>0.05)。结论短期口服替米沙坦可以明显改善CHF患者的血栓前状态,这可能与其降低CHF的栓塞危险和改善其预后有关。[Objective] To study the effect of Telmisartan on the prethmmbotic state in congestive heart failure (CHF). [Methods] 45 patients in CHF were divided randomly into Telmisartan group(Micardis 80 mg qd×14 days ) and Control group, Control group did not administrate Telmisartan, the other drugs were same as Telmisartan group. Tissue plasminogen activator activity (tPA), tissue plasminogen activator inhibitor-1 activity (PAI-1), Plasma D- dimer (D-D) and von Willebrand factor (vWF) level were measured in 2 group CHF patients with heart function class Ⅱ to IV before and 2 weeks after administration. [Results] Plasma tPA, PAI-1, vWF and D-D level before drug administration were not significantly different between 2 groups (P 〉0.05). Plasma tPA activity after drug administration in Telmisartan group was higher (P 〈0.05), but Plasma PAI-1, vWF and D-D level were significantly lower (P 〈0.05), and the level of above all indexes in control group were not significantly decreased after administration (P〉0.05). Compared with control group, plasma PAI-1, vWF and D-D level after drug administration in telmisartan group were significantly lower (P 〈0.05), but plasma tPA activity was not significantly increased (P 〉 0.05). [Conclusion] Telmisartan can improve the prethrombotic state in congestive heart failure, which may be correlated with decreasement of thrombembolia and death risk in CHF patients.
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在链接到云南高校图书馆文献保障联盟下载...
云南高校图书馆联盟文献共享服务平台 版权所有©
您的IP:216.73.216.175